(NYSE: SOLV) Solventum's forecast annual revenue growth rate of 1.35% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 10.66%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.4%.
Solventum's revenue in 2026 is $8,402,000,000.On average, 16 Wall Street analysts forecast SOLV's revenue for 2026 to be $1,412,903,799,322, with the lowest SOLV revenue forecast at $1,306,233,551,767, and the highest SOLV revenue forecast at $1,476,732,500,298. On average, 14 Wall Street analysts forecast SOLV's revenue for 2027 to be $1,460,428,429,940, with the lowest SOLV revenue forecast at $1,347,514,070,333, and the highest SOLV revenue forecast at $1,524,257,130,916.
In 2028, SOLV is forecast to generate $1,521,655,417,561 in revenue, with the lowest revenue forecast at $1,443,604,016,911 and the highest revenue forecast at $1,586,698,251,436.